ReviewBiosensors2026
DNA Origami and Their Application in Biosensors.
Review in Biosensors, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Biosensors have evolved significantly since their invention in the mid-twentieth century. From a simple electrochemical device to the current inclusion of AI, these sophisticated tools are capable of label-free, real-time multiplex detection. To make these sensing systems even more powerful, the incorporation of DNA origami has allowed this technology to become extremely precise, recognisable, and programmable to a range of molecules. This paper systematically summarises the incorporation of DNA origami with biosensors such as fluorescence, surface-enhanced Raman spectroscopy (SERS), surface plasmon resonance (SPR), and electrochemical sensors as well as approaches that are used to design DNA origami nanostructures. These tools allow a range of targets to be detected, ranging from small molecules to larger biological species. Collectively, these studies demonstrate that DNA origami-based biosensors provide high sensitivity; precise spatial control; and rapid, modular detection capabilities. Furthermore, their versatility enables applications across a diverse range of sectors. However, key challenges including limited reproducibility, structural instability, photobleaching, and non-specific binding continue to hinder their widespread adoption. This review proposes future directions aimed at overcoming key limitations, including enhancing biocompatibility and structural stability, to support the development of more advanced and clinical point-of-care-applicable biosensors.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.